Literature DB >> 3966941

Beneficial effect of intravenous cyclophosphamide and oral prednisone on D-penicillamine-associated bronchiolitis obliterans.

M A van de Laar, C J Westermann, S S Wagenaar, H J Dinant.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3966941     DOI: 10.1002/art.1780280115

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  7 in total

1.  Open lung biopsy of patients with rheumatoid arthritis.

Authors:  M Hakala; P Pääkkö; E Huhti; M Tarkka; S Sutinen
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

2.  Association of bronchiolitis with connective tissue disorders.

Authors:  M Hakala; P Pääkkö; S Sutinen; E Huhti; O Koivisto; M Tarkka
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

3.  Bronchiolitis obliterans in systemic lupus erythematosus: beneficial effect of intravenous cyclophosphamide.

Authors:  B Godeau; C Cormier; C J Menkes
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

Review 4.  Bronchiolitis obliterans.

Authors:  Petey Laohaburanakit; Andrew Chan; Roblee P Allen
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

5.  Obliterative bronchiolitis associated with rheumatoid arthritis: analysis of a single-center case series.

Authors:  Erica Lin; Andrew H Limper; Teng Moua
Journal:  BMC Pulm Med       Date:  2018-06-22       Impact factor: 3.317

6.  A case of imatinib-related obstructive bronchiolitis followed long term.

Authors:  Chika Yajima; Nariaki Kokuho; Kazutoshi Toriyama; Junichiro Kawagoe; Yuki Togashi; Jun Matsubayashi; Hideaki Nakayama; Yasuhiro Setoguchi; Shinji Abe
Journal:  Respir Med Case Rep       Date:  2020-04-04

Review 7.  Bronchiolitis obliterans.

Authors:  T E King
Journal:  Lung       Date:  1989       Impact factor: 2.584

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.